Titan Pharmaceuticals
TTNP
#10544
Rank
A$8.57 M
Marketcap
A$6.44
Share price
-3.76%
Change (1 day)
4.06%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$6.58 Million, an increase over its 2023 earnings that were of -A$7.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-34.29%
2024 -A$6.58 Million-15.5%
2023 -A$7.79 Million-45.43%
2022 -A$14.27 Million16.29%
2021 -A$12.27 Million-907.36%
2020 A$1.51 M-106.6%
2019 -A$23.01 Million82.4%
2018 -A$12.62 Million-36.93%
2017 -A$20.01 Million-378.62%
2016 A$7.17 M-145.53%
2015 -A$15.77 Million369.37%
2014 -A$3.36 Million-125.9%
2013 A$12.97 M-177.74%
2012 -A$16.69 Million13.59%
2011 -A$14.69 Million74.37%
2010 -A$8.43 Million3.61%
2009 -A$8.13 Million
2007 -A$25.77 Million12.08%
2006 -A$23 Million-28.65%
2005 -A$32.23 Million-10.03%
2004 -A$35.82 Million-6.08%
2003 -A$38.14 Million-14.76%
2002 -A$44.75 Million32.52%
2001 -A$33.77 Million27.55%
2000 -A$26.47 Million62.5%
1999 -A$16.29 Million4.04%
1998 -A$15.66 Million49.33%
1997 -A$10.49 Million-27.88%
1996 -A$14.54 Million13.04%
1995 -A$12.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.31 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.06 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.17 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.11 B-3,090.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$16.79 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion 10,144.78%๐Ÿ‡บ๐Ÿ‡ธ USA